Anirvan Ghosh, Unity CEO (via Facebook)
Unity finds itself with a finite amount of cash as new data provide a ray of hope for investors
It has not been an easy road for the anti-aging startup Unity Biotechnology. From staff cuts to a lead program loss, the company has run …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
